| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Nov 19, 2025 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 41.3 | -2,812 | -2.64% | ✓ | $213.7K |
| Oct 7, 2025 | Oct 9, 2025 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 37.5 | -3,375 | -3.15% | ✓ | $214.1K |
| Oct 3, 2025 | Oct 7, 2025 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 36.3 | -24,921 | -2.08% | ✓ | $1.6M |
| Sep 11, 2025 | Sep 15, 2025 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 27.5 | -47,249 | -6.10% | ✓ | $2.9M |
| Aug 15, 2025 | Aug 19, 2025 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 41.3 | -2,813 | -2.64% | ✓ | $136.7K |
| May 15, 2025 | May 19, 2025 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 45.0 | -2,812 | -1.34% | ✓ | $129.7K |
| Mar 12, 2025 | Mar 14, 2025 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 30.0 | -15,521 | -6.95% | ✓ | $827.2K |
| Mar 10, 2025 | Mar 12, 2025 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 20.0 | -75,420 | -10.67% | ✓ | $4M |
| Feb 19, 2025 | Feb 21, 2025 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 42.5 | -2,947 | -2.76% | ✗ | $147.7K |
| Jan 7, 2025 | Jan 10, 2025 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 42.5 | -3,541 | -3.21% | ✗ | $158.9K |
| Dec 2, 2024 | Dec 4, 2024 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 18.8 | -95,908 | -12.89% | ✓ | $5M |
| Jan 30, 2024 | Feb 1, 2024 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 46.3 | -794 | -1.10% | ✗ | $21.6K |
| Jan 8, 2024 | Jan 10, 2024 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 42.5 | -3,395 | -4.50% | ✗ | $98K |
| Apr 17, 2023 | Apr 19, 2023 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 5.0 | -61,923 | -29.12% | ✓ | $3.2M |
| Jan 31, 2023 | Feb 2, 2023 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 46.3 | -812 | -1.07% | ✗ | $37K |
| Jan 10, 2023 | Jan 12, 2023 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 46.3 | -1,085 | -1.40% | ✗ | $47.3K |
| Jan 9, 2023 | Jan 11, 2023 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 46.3 | -835 | -1.07% | ✗ | $34.8K |
| Oct 17, 2022 | Oct 19, 2022 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 38.8 | -6,901 | -2.75% | ✓ | $379.6K |
| Sep 20, 2022 | Sep 22, 2022 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 47.5 | -1,176 | -0.95% | ✓ | $64.7K |
| Apr 13, 2022 | Apr 15, 2022 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 37.5 | -2,276 | -3.59% | ✓ | $102.8K |
| Apr 5, 2022 | Apr 7, 2022 | PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sell | 58.8 | -5 | -0.01% | ✓ | $225 |
| Feb 10, 2022 | Feb 11, 2022 | PTC THERAPEUTICS, INC. | Exec. VP and CLO | Sell | 22.5 | -17,935 | -12.80% | ✓ | $807.6K |
| Feb 1, 2022 | Feb 3, 2022 | PTC THERAPEUTICS, INC. | Exec. VP and CLO | Sell | 46.3 | -779 | -1.26% | ✗ | $31.2K |
| Jan 7, 2022 | Jan 11, 2022 | PTC THERAPEUTICS, INC. | Exec. VP and CLO | Sell | 91.3 | +13,515 | 27.94% | ✗ | $34.1K |
| Sep 2, 2021 | Sep 3, 2021 | PTC THERAPEUTICS, INC. | Exec. VP and CLO | Sell | 32.5 | -3,363 | -6.50% | ✓ | $151.4K |
| Jul 8, 2021 | Jul 12, 2021 | PTC THERAPEUTICS, INC. | Exec. VP and CLO | Sell | 42.5 | -9,234 | -1.87% | ✓ | $417.3K |
| Feb 1, 2021 | Feb 2, 2021 | PTC THERAPEUTICS, INC. | Exec. VP and CLO | Sell | 46.3 | -778 | -1.58% | ✗ | $44.3K |
| Jan 5, 2021 | Jan 7, 2021 | PTC THERAPEUTICS, INC. | Exec. VP and CLO | Sell | 46.3 | -772 | -1.94% | ✗ | $48.1K |
| Jul 7, 2020 | Jul 9, 2020 | PTC THERAPEUTICS, INC. | Exec. VP and CLO | Sell | 32.5 | -30,625 | -3.52% | ✓ | $1.7M |
| Jul 5, 2019 | Jul 9, 2019 | PTC THERAPEUTICS, INC. | Exec. VP and CLO | Sell | 30.0 | -15,312 | -5.97% | ✓ | $685.1K |
| Jun 28, 2019 | Jul 2, 2019 | PTC THERAPEUTICS, INC. | Exec. VP and CLO | Sell | 3.8 | -181,667 | -35.87% | ✓ | $8.2M |
| Jun 8, 2015 | Jun 10, 2015 | PTC THERAPEUTICS, INC. | Exec VP and CLO | Sell | 5.0 | -56,849 | -77.69% | ✓ | $3.1M |
| Mar 20, 2015 | Mar 23, 2015 | PTC THERAPEUTICS, INC. | Exec. VP and CLO | Sell | 5.0 | -21,142 | -65.59% | ✓ | $1.4M |
| Mar 20, 2014 | Mar 21, 2014 | PTC THERAPEUTICS, INC. | Exec. VP and CLO | Sell | 12.5 | -10,049 | -23.77% | ✓ | $311.1K |